Back to Results
First PageMeta Content



Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich
Add to Reading List

Document Date: 2016-05-30 21:34:45


Open Document

File Size: 156,90 KB

Share Result on Facebook